Literature DB >> 33200536

The impact of robotics in liver surgery: A worldwide systematic review and short-term outcomes meta-analysis on 2,728 cases.

Ruben Ciria1, Giammauro Berardi2,3, Felipe Alconchel4, Javier Briceño1, Gi Hong Choi5, Yao-Ming Wu6, Atsushi Sugioka7, Roberto Ivan Troisi3,8,9, Chady Salloum10,11, Olivier Soubrane12, Johann Pratschke13, John Martinie14, Allan Tsung15, Raphael Araujo16,17,18, Iswanto Sucandy19, Chung N Tang20, Go Wakabayashi2.   

Abstract

BACKGROUND: The dissemination of robotic liver surgery is slow-paced and must face the obstacle of demonstrating advantages over open and laparoscopic (LLS) approaches. Our objective was to show the current position of robotic liver surgery (RLS) worldwide and to identify if improved short-term outcomes are observed, including secondary meta-analyses for type of resection, etiology, and cost analysis.
METHODS: A PRISMA-based systematic review was performed to identify manuscripts comparing RLS vs open or LLS approaches. Quality analysis was performed using the Newcatle-Ottawa score. Statistical analysis was performed after heterogeneity test and fixed- or random-effect models were chosen accordingly.
RESULTS: After removing duplications, 2728 RLS cases were identified from the final set of 150 manuscripts. More than 75% of the cases have been performed on malignancies. Meta-analysis from the 38 comparative reports showed that RLS may offer improved short-term outcomes compared to open procedures in most of the variables screened. Compared to LLS, some advantages may be observed in favour of RLS for major resections in terms of operative time, hospital stay and rate of complications. Cost analyses showed an increased cost per procedure of around US$5000.
CONCLUSIONS: The advantages of RLS still need to be demonstrated although early results are promising. Advantages vs open approach are demonstrated. Compared to laparoscopic surgery, minor perioperative advantages may be observed for major resections although cost analyses are still unfavorable to the robotic approach.
© 2020 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  laparoscopic liver surgery; liver surgery; minimally invasive surgery; robotics

Mesh:

Year:  2020        PMID: 33200536     DOI: 10.1002/jhbp.869

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  12 in total

1.  Robotic and laparoscopic right anterior sectionectomy and central hepatectomy: multicentre propensity score-matched analysis.

Authors:  Hye Yeon Yang; Gi Hong Choi; Ken-Min Chin; Sung Hoon Choi; Nicholas L Syn; Tan-To Cheung; Adrian K H Chiow; Iswanto Sucandy; Marco V Marino; Mikel Prieto; Charing C Chong; Jae Hoon Lee; Mikhail Efanov; T Peter Kingham; Robert P Sutcliffe; Roberto I Troisi; Johann Pratschke; Xiaoying Wang; Mathieu D'Hondt; Chung Ngai Tang; Rong Liu; James O Park; Fernando Rotellar; Olivier Scatton; Atsushi Sugioka; Tran Cong Duy Long; Chung-Yip Chan; David Fuks; Ho-Seong Han; Brian K P Goh
Journal:  Br J Surg       Date:  2022-03-15       Impact factor: 6.939

2.  Robotic biliary surgery for benign and malignant bile duct obstruction: a case series.

Authors:  Mathieu D'Hondt; Dennis A Wicherts
Journal:  J Robot Surg       Date:  2022-03-21

3.  Minimally invasive treatment of colorectal liver metastases: does robotic surgery provide any technical advantages over laparoscopy? A multicenter analysis from the IGoMILS (Italian Group of Minimally Invasive Liver Surgery) registry.

Authors:  Michele Masetti; Guido Fallani; Luca Aldrighetti; Elio Jovine; Francesca Ratti; Alessandro Ferrero; Felice Giuliante; Umberto Cillo; Alfredo Guglielmi; Giuseppe Maria Ettorre; Guido Torzilli; Leonardo Vincenti; Giorgio Ercolani; Chiara Cipressi; Raffaele Lombardi
Journal:  Updates Surg       Date:  2022-01-31

4.  Comparison of robotic and laparoscopic liver resection in ordinary cases of left lateral sectionectomy.

Authors:  Lin Zhu; Yanzhe Liu; Minggen Hu; Zhiming Zhao; Chenggang Li; Xuan Zhang; Xianglong Tan; Fei Wang; Rong Liu
Journal:  Surg Endosc       Date:  2021-11-08       Impact factor: 3.453

5.  Robotic liver resection for hepatocellular carcinoma: analysis of surgical margins and clinical outcomes from a western tertiary hepatobiliary center.

Authors:  Emanuel Shapera; Kaitlyn Crespo; Cameron Syblis; Sharona Ross; Alexander Rosemurgy; Iswanto Sucandy
Journal:  J Robot Surg       Date:  2022-10-21

6.  Transition from laparoscopic to robotic liver surgery: clinical outcomes, learning curve effect, and cost-effectiveness.

Authors:  M D'Hondt; A Devooght; E Willems; D Wicherts; C De Meyere; I Parmentier; A Provoost; H Pottel; C Verslype
Journal:  J Robot Surg       Date:  2022-03-24

7.  Liver resection vs radiofrequency ablation in single hepatocellular carcinoma of posterosuperior segments in elderly patients.

Authors:  Antonella Delvecchio; Riccardo Inchingolo; Rita Laforgia; Francesca Ratti; Maximiliano Gelli; Massimiliano Ferdinando Anelli; Alexis Laurent; Giulio Vitali; Paolo Magistri; Giacomo Assirati; Emanuele Felli; Taiga Wakabayashi; Patrick Pessaux; Tullio Piardi; Fabrizio di Benedetto; Nicola de'Angelis; Javier Briceño; Antonio Rampoldi; Renè Adam; Daniel Cherqui; Luca Antonio Aldrighetti; Riccardo Memeo
Journal:  World J Gastrointest Surg       Date:  2021-12-27

8.  Robotic Extrahepatic Biliary Resection with Roux-en-Y Hepaticojejunostomy for Type 2 Klatskin Tumor.

Authors:  Iswanto Sucandy; Sharona B Ross; Kaitlyn L Crespo; Alexander S Rosemurgy
Journal:  Ann Surg Oncol       Date:  2021-08-09       Impact factor: 5.344

9.  The effect of diabetes on major robotic hepatectomy.

Authors:  Aryan Modasi; Iswanto Sucandy; Sharona Ross; Emily Krill; Miguel Castro; Trenton Lippert; Kenneth Luberice; Alexander Rosemurgy
Journal:  J Robot Surg       Date:  2021-03-08

Review 10.  Robotic-Assisted Surgery for Primary Hepatobiliary Tumors-Possibilities and Limitations.

Authors:  Julia Spiegelberg; Tanja Iken; Markus K Diener; Stefan Fichtner-Feigl
Journal:  Cancers (Basel)       Date:  2022-01-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.